{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T01:58:15Z","timestamp":1788400695440,"version":"build-2803163510"},"reference-count":170,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T00:00:00Z","timestamp":1777334400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-026-03021-6","type":"journal-article","created":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:50:16Z","timestamp":1777373416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The hypoxia-inflammation cycle as a key mechanism of smoldering inflammation and progression in multiple sclerosis"],"prefix":"10.1007","volume":"151","author":[{"given":"M.","family":"Missaglia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Filippi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,28]]},"reference":[{"key":"3021_CR1","doi-asserted-by":"publisher","first-page":"1679","DOI":"10.1177\/13524585211013748","volume":"27","author":"M Absinta","year":"2021","unstructured":"Absinta M, Dal-Bianco A (2021) Slowly expanding lesions are a marker of progressive MS\u2014yes. Mult Scler 27:1679\u20131681. https:\/\/doi.org\/10.1177\/13524585211013748","journal-title":"Mult Scler"},{"key":"3021_CR2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1097\/WCO.0000000000000818","volume":"33","author":"M Absinta","year":"2020","unstructured":"Absinta M, Lassmann H, Trapp BD (2020) Mechanisms underlying progression in multiple sclerosis. Curr Opin Neurol 33:277\u2013285. https:\/\/doi.org\/10.1097\/WCO.0000000000000818","journal-title":"Curr Opin Neurol"},{"key":"3021_CR3","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/s41586-021-03892-7","volume":"597","author":"M Absinta","year":"2021","unstructured":"Absinta M, Maric D, Gharagozloo M, Garton T, Smith MD, Jin J et al (2021) A lymphocyte\u2013microglia\u2013astrocyte axis in chronic active multiple sclerosis. Nature 597:709\u2013714. https:\/\/doi.org\/10.1038\/s41586-021-03892-7","journal-title":"Nature"},{"key":"3021_CR4","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.3174\/ajnr.A5660","volume":"39","author":"M Absinta","year":"2018","unstructured":"Absinta M, Sati P, Fechner A, Schindler MK, Nair G, Reich DS (2018) Identification of chronic active multiple sclerosis lesions on 3T MRI. AJNR Am J Neuroradiol 39:1233\u20131238. https:\/\/doi.org\/10.3174\/ajnr.A5660","journal-title":"AJNR Am J Neuroradiol"},{"key":"3021_CR5","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1001\/jamaneurol.2019.2399","volume":"76","author":"M Absinta","year":"2019","unstructured":"Absinta M, Sati P, Masuzzo F, Nair G, Sethi V, Kolb H et al (2019) Association of chronic active multiple sclerosis lesions with disability in vivo. JAMA Neurol 76:1474. https:\/\/doi.org\/10.1001\/jamaneurol.2019.2399","journal-title":"JAMA Neurol"},{"key":"3021_CR6","doi-asserted-by":"publisher","first-page":"2597","DOI":"10.1172\/JCI86198","volume":"126","author":"M Absinta","year":"2016","unstructured":"Absinta M, Sati P, Schindler M, Leibovitch EC, Ohayon J, Wu T et al (2016) Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. J Clin Invest 126:2597\u20132609. https:\/\/doi.org\/10.1172\/JCI86198","journal-title":"J Clin Invest"},{"key":"3021_CR7","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12974-016-0502-1","volume":"13","author":"M Albanese","year":"2016","unstructured":"Albanese M, Zagaglia S, Landi D, Boffa L, Nicoletti CG, Marciani MG et al (2016) Cerebrospinal fluid lactate is associated with multiple sclerosis disease progression. J Neuroinflammation 13:36. https:\/\/doi.org\/10.1186\/s12974-016-0502-1","journal-title":"J Neuroinflammation"},{"key":"3021_CR8","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.stem.2020.09.019","volume":"28","author":"KC Allan","year":"2021","unstructured":"Allan KC, Hu LR, Scavuzzo MA, Morton AR, Gevorgyan AS, Cohn EF et al (2021) Non-canonical targets of HIF1a impair oligodendrocyte progenitor cell function. Cell Stem Cell 28:257-272.e11. https:\/\/doi.org\/10.1016\/j.stem.2020.09.019","journal-title":"Cell Stem Cell"},{"key":"3021_CR9","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1177\/13524585221114750","volume":"28","author":"AI Altokhis","year":"2022","unstructured":"Altokhis AI, Hibbert AM, Allen CM, Mougin O, Alotaibi A, Lim S-Y et al (2022) Longitudinal clinical study of patients with iron rim lesions in multiple sclerosis. Mult Scler 28:2202\u20132211. https:\/\/doi.org\/10.1177\/13524585221114750","journal-title":"Mult Scler"},{"key":"3021_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1271118","volume":"14","author":"JJ Anders","year":"2023","unstructured":"Anders JJ, Elwood BW, Kardon RH, Gramlich OW (2023) Acriflavine, a HIF-1 inhibitor, preserves vision in an experimental autoimmune encephalomyelitis model of optic neuritis. Front Immunol 14:1271118. https:\/\/doi.org\/10.3389\/fimmu.2023.1271118","journal-title":"Front Immunol"},{"key":"3021_CR11","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1007\/s10571-021-01111-5","volume":"42","author":"R Asgari","year":"2021","unstructured":"Asgari R, Yarani R, Mohammadi P, Emami Aleagha MS (2021) HIF-1\u03b1 in the crosstalk between reactive oxygen species and autophagy process: a review in multiple sclerosis. Cell Mol Neurobiol 42:2121\u20132129. https:\/\/doi.org\/10.1007\/s10571-021-01111-5","journal-title":"Cell Mol Neurobiol"},{"key":"3021_CR12","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1093\/brain\/awr278","volume":"134","author":"F Bagnato","year":"2011","unstructured":"Bagnato F, Hametner S, Yao B, van Gelderen P, Merkle H, Cantor FK et al (2011) Tracking iron in multiple sclerosis: a combined imaging and histopathological study at 7 tesla. Brain 134:3602\u20133615. https:\/\/doi.org\/10.1093\/brain\/awr278","journal-title":"Brain"},{"key":"3021_CR13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae013","author":"F Bagnato","year":"2024","unstructured":"Bagnato F, Sati P, Hemond CC, Elliott C, Gauthier SA, Harrison DM et al (2024) Imaging chronic active lesions in multiple sclerosis: a consensus statement. Brain. https:\/\/doi.org\/10.1093\/brain\/awae013","journal-title":"Brain"},{"key":"3021_CR14","doi-asserted-by":"publisher","first-page":"18351","DOI":"10.1073\/pnas.1318345110","volume":"110","author":"K Bartels","year":"2013","unstructured":"Bartels K, Grenz A, Eltzschig HK (2013) Hypoxia and inflammation are two sides of the same coin. Proc Natl Acad Sci USA 110:18351\u201318352. https:\/\/doi.org\/10.1073\/pnas.1318345110","journal-title":"Proc Natl Acad Sci USA"},{"key":"3021_CR15","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1002\/eji.200838318","volume":"38","author":"J Ben-Shoshan","year":"2008","unstructured":"Ben-Shoshan J, Maysel-Auslender S, Mor A, Keren G, George J (2008) Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1alpha. Eur J Immunol 38:2412\u20132418. https:\/\/doi.org\/10.1002\/eji.200838318","journal-title":"Eur J Immunol"},{"key":"3021_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2021-000240","volume":"4","author":"V Beynon","year":"2022","unstructured":"Beynon V, George IC, Elliott C, Arnold DL, Ke J, Chen H et al (2022) Chronic lesion activity and disability progression in secondary progressive multiple sclerosis. BMJ Neurol Open 4:e000240. https:\/\/doi.org\/10.1136\/bmjno-2021-000240","journal-title":"BMJ Neurol Open"},{"key":"3021_CR17","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41582-023-00839-6","volume":"19","author":"S Bittner","year":"2023","unstructured":"Bittner S, Pape K, Klotz L, Zipp F (2023) Implications of immunometabolism for smouldering MS pathology and therapy. Nat Rev Neurol 19:477\u2013488. https:\/\/doi.org\/10.1038\/s41582-023-00839-6","journal-title":"Nat Rev Neurol"},{"key":"3021_CR18","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s00401-013-1112-y","volume":"125","author":"A Boyd","year":"2013","unstructured":"Boyd A, Zhang H, Williams A (2013) Insufficient OPC migration into demyelinated lesions is a cause of poor remyelination in MS and mouse models. Acta Neuropathol 125:841\u2013859. https:\/\/doi.org\/10.1007\/s00401-013-1112-y","journal-title":"Acta Neuropathol"},{"key":"3021_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2021.101343","volume":"68","author":"J Burtscher","year":"2021","unstructured":"Burtscher J, Mallet RT, Burtscher M, Millet GP (2021) Hypoxia and brain aging: neurodegeneration or neuroprotection? Ageing Res Rev 68:101343. https:\/\/doi.org\/10.1016\/j.arr.2021.101343","journal-title":"Ageing Res Rev"},{"key":"3021_CR20","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1002\/1873-3468.13013","volume":"592","author":"G Campbell","year":"2018","unstructured":"Campbell G, Mahad DJ (2018) Mitochondrial dysfunction and axon degeneration in progressive multiple sclerosis. FEBS Lett 592:1113\u20131121. https:\/\/doi.org\/10.1002\/1873-3468.13013","journal-title":"FEBS Lett"},{"key":"3021_CR21","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1002\/ana.22109","volume":"69","author":"GR Campbell","year":"2011","unstructured":"Campbell GR, Ziabreva I, Reeve AK, Krishnan KJ, Reynolds R, Howell O et al (2011) Mitochondrial DNA deletions and neurodegeneration in multiple sclerosis. Ann Neurol 69:481\u2013492. https:\/\/doi.org\/10.1002\/ana.22109","journal-title":"Ann Neurol"},{"key":"3021_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e17986","author":"Y Cao","year":"2023","unstructured":"Cao Y, Yue X, Jia M, Wang J (2023) Neuroinflammation and anti-inflammatory therapy for ischemic stroke. Heliyon. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17986","journal-title":"Heliyon"},{"key":"3021_CR23","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1038\/s41467-019-11139-3","volume":"10","author":"KE Carlstr\u00f6m","year":"2019","unstructured":"Carlstr\u00f6m KE, Ewing E, Granqvist M, Gyllenberg A, Aeinehband S, Enoksson SL et al (2019) Therapeutic efficacy of dimethyl fumarate in relapsing-remitting multiple sclerosis associates with ROS pathway in monocytes. Nat Commun 10:3081. https:\/\/doi.org\/10.1038\/s41467-019-11139-3","journal-title":"Nat Commun"},{"key":"3021_CR24","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1093\/brain\/awf216","volume":"125","author":"P Charles","year":"2002","unstructured":"Charles P, Reynolds R, Seilhean D, Rougon G, Aigrot MS, Niezgoda A et al (2002) Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis? Brain 125:1972\u20131979. https:\/\/doi.org\/10.1093\/brain\/awf216","journal-title":"Brain"},{"key":"3021_CR25","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1038\/nature19334","volume":"537","author":"SH Cho","year":"2016","unstructured":"Cho SH, Raybuck AL, Stengel K, Wei M, Beck TC, Volanakis E et al (2016) Germinal centre hypoxia and regulation of antibody qualities by a hypoxia response system. Nature 537:234\u2013238. https:\/\/doi.org\/10.1038\/nature19334","journal-title":"Nature"},{"key":"3021_CR26","doi-asserted-by":"publisher","first-page":"4465","DOI":"10.3390\/ijms25084465","volume":"25","author":"YK Choi","year":"2024","unstructured":"Choi YK (2024) Detrimental roles of hypoxia-inducible factor-1\u03b1 in severe hypoxic brain diseases. Int J Mol Sci 25:4465. https:\/\/doi.org\/10.3390\/ijms25084465","journal-title":"Int J Mol Sci"},{"key":"3021_CR27","doi-asserted-by":"publisher","first-page":"E2784","DOI":"10.1073\/pnas.1202366109","volume":"109","author":"ET Clambey","year":"2012","unstructured":"Clambey ET, McNamee EN, Westrich JA, Glover LE, Campbell EL, Jedlicka P et al (2012) Hypoxia-inducible factor-1 alpha-dependent induction of FoxP3 drives regulatory T-cell abundance and function during inflammatory hypoxia of the mucosa. Proc Natl Acad Sci USA 109:E2784-2793. https:\/\/doi.org\/10.1073\/pnas.1202366109","journal-title":"Proc Natl Acad Sci USA"},{"key":"3021_CR28","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1146\/annurev-immunol-100819-121537","volume":"38","author":"SP Colgan","year":"2020","unstructured":"Colgan SP, Furuta GT, Taylor CT (2020) Hypoxia and innate immunity: keeping up with the HIFsters. Annu Rev Immunol 38:341\u2013363. https:\/\/doi.org\/10.1146\/annurev-immunol-100819-121537","journal-title":"Annu Rev Immunol"},{"key":"3021_CR29","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/S0140-6736(08)61620-7","volume":"372","author":"A Compston","year":"2008","unstructured":"Compston A, Coles A (2008) Multiple sclerosis. Lancet 372:1502\u20131517. https:\/\/doi.org\/10.1016\/S0140-6736(08)61620-7","journal-title":"Lancet"},{"key":"3021_CR30","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.nic.2008.09.002","volume":"18","author":"C Confavreux","year":"2008","unstructured":"Confavreux C, Vukusic S (2008) The clinical epidemiology of multiple sclerosis. Neuroimaging Clin N Am 18:589\u2013622. https:\/\/doi.org\/10.1016\/j.nic.2008.09.002","journal-title":"Neuroimaging Clin N Am"},{"key":"3021_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/s0092-8674(03)00154-5","volume":"112","author":"T Cramer","year":"2003","unstructured":"Cramer T, Yamanishi Y, Clausen BE, F\u00f6rster I, Pawlinski R, Mackman N et al (2003) HIF-1alpha is essential for myeloid cell-mediated inflammation. Cell 112:645\u2013657. https:\/\/doi.org\/10.1016\/s0092-8674(03)00154-5","journal-title":"Cell"},{"key":"3021_CR32","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00401-016-1636-z","volume":"133","author":"A Dal-Bianco","year":"2017","unstructured":"Dal-Bianco A, Grabner G, Kronnerwetter C, Weber M, H\u00f6ftberger R, Berger T et al (2017) Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging. Acta Neuropathol 133:25\u201342. https:\/\/doi.org\/10.1007\/s00401-016-1636-z","journal-title":"Acta Neuropathol"},{"key":"3021_CR33","doi-asserted-by":"publisher","DOI":"10.1177\/17562864241306684","volume":"17","author":"A Dal-Bianco","year":"2024","unstructured":"Dal-Bianco A, Oh J, Sati P, Absinta M (2024) Chronic active lesions in multiple sclerosis: classification, terminology, and clinical significance. Ther Adv Neurol Disord 17:17562864241306684. https:\/\/doi.org\/10.1177\/17562864241306684","journal-title":"Ther Adv Neurol Disord"},{"key":"3021_CR34","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1016\/j.cell.2011.07.033","volume":"146","author":"EV Dang","year":"2011","unstructured":"Dang EV, Barbi J, Yang H-Y, Jinasena D, Yu H, Zheng Y et al (2011) Control of T(H)17\/T(reg) balance by hypoxia-inducible factor 1. Cell 146:772\u2013784. https:\/\/doi.org\/10.1016\/j.cell.2011.07.033","journal-title":"Cell"},{"key":"3021_CR35","doi-asserted-by":"publisher","first-page":"5654","DOI":"10.1073\/pnas.1222560110","volume":"110","author":"M D\u2019haeseleer","year":"2013","unstructured":"D\u2019haeseleer M, Beelen R, Fierens Y, Cambron M, Vanbinst A-M, Verborgh C et al (2013) Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1. Proc Natl Acad Sci USA 110:5654\u20135658. https:\/\/doi.org\/10.1073\/pnas.1222560110","journal-title":"Proc Natl Acad Sci USA"},{"key":"3021_CR36","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.33242","author":"IM Dighriri","year":"2023","unstructured":"Dighriri IM, Aldalbahi AA, Albeladi F, Tahiri AA, Kinani EM, Almohsen RA et al (2023) An overview of the history, pathophysiology, and pharmacological interventions of multiple sclerosis. Cureus. https:\/\/doi.org\/10.7759\/cureus.33242","journal-title":"Cureus"},{"key":"3021_CR37","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/febs.13578","volume":"283","author":"L D\u2019Ignazio","year":"2016","unstructured":"D\u2019Ignazio L, Bandarra D, Rocha S (2016) NF-\u03baB and HIF crosstalk in immune responses. FEBS J 283:413\u2013424. https:\/\/doi.org\/10.1111\/febs.13578","journal-title":"FEBS J"},{"key":"3021_CR38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ene.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis\u2014a review. Eur J Neurol 26:27\u201340. https:\/\/doi.org\/10.1111\/ene.13819","journal-title":"Eur J Neurol"},{"key":"3021_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1137635","author":"E Duarte-Silva","year":"2023","unstructured":"Duarte-Silva E, Meuth SG, Peixoto CA (2023) The role of iron metabolism in the pathogenesis and treatment of multiple sclerosis. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2023.1137635","journal-title":"Front Immunol"},{"key":"3021_CR40","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000275229.13012.32","author":"R Dutta","year":"2007","unstructured":"Dutta R, Trapp BD (2007) Pathogenesis of axonal and neuronal damage in multiple sclerosis. Neurology. https:\/\/doi.org\/10.1212\/01.wnl.0000275229.13012.32","journal-title":"Neurology"},{"key":"3021_CR41","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1177\/1352458518814117","volume":"25","author":"C Elliott","year":"2019","unstructured":"Elliott C, Wolinsky JS, Hauser SL, Kappos L, Barkhof F, Bernasconi C et al (2019) Slowly expanding\/evolving lesions as a magnetic resonance imaging marker of chronic active multiple sclerosis lesions. Mult Scler 25:1915\u20131925. https:\/\/doi.org\/10.1177\/1352458518814117","journal-title":"Mult Scler"},{"key":"3021_CR42","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656\u2013665. https:\/\/doi.org\/10.1056\/NEJMra0910283","journal-title":"N Engl J Med"},{"key":"3021_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.neubiorev.2024.105788","volume":"164","author":"R Emamnejad","year":"2024","unstructured":"Emamnejad R, Pagnin M, Petratos S (2024) The iron maiden: oligodendroglial metabolic dysfunction in multiple sclerosis and mitochondrial signaling. Neurosci Biobehav Rev 164:105788. https:\/\/doi.org\/10.1016\/j.neubiorev.2024.105788","journal-title":"Neurosci Biobehav Rev"},{"key":"3021_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103488","volume":"58","author":"M Etemadifar","year":"2022","unstructured":"Etemadifar M, Salari M, Esnaashari A, Ghazanfaripoor F, Sayahi F, Akhavan Sigari A et al (2022) Atherosclerosis and multiple sclerosis: an overview on the prevalence of risk factors. Mult Scler Relat Disord 58:103488. https:\/\/doi.org\/10.1016\/j.msard.2022.103488","journal-title":"Mult Scler Relat Disord"},{"key":"3021_CR45","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1474-4422(18)30451-4","volume":"18","author":"M Filippi","year":"2019","unstructured":"Filippi M, Br\u00fcck W, Chard D, Fazekas F, Geurts JJG, Enzinger C et al (2019) Association between pathological and MRI findings in Multiple Sclerosis. Lancet Neurol 18:198\u2013210. https:\/\/doi.org\/10.1016\/S1474-4422(18)30451-4","journal-title":"Lancet Neurol"},{"key":"3021_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-025-03592-3","volume":"22","author":"K Fischer","year":"2025","unstructured":"Fischer K, Thewes L, Prozorovski T, Bayer M, Dietrich M, Lowin T et al (2025) Fumarate-based drugs protect against neuroinflammation via upregulation of anti-ferroptotic pathways. J Neuroinflammation 22:241. https:\/\/doi.org\/10.1186\/s12974-025-03592-3","journal-title":"J Neuroinflammation"},{"key":"3021_CR47","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1038\/nature11007","volume":"485","author":"U F\u00fcnfschilling","year":"2012","unstructured":"F\u00fcnfschilling U, Supplie LM, Mahad D, Boretius S, Saab AS, Edgar J et al (2012) Glycolytic oligodendrocytes maintain myelin and long-term axonal integrity. Nature 485:517\u2013521. https:\/\/doi.org\/10.1038\/nature11007","journal-title":"Nature"},{"key":"3021_CR48","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1007\/s10571-023-01388-8","volume":"43","author":"X Gao","year":"2023","unstructured":"Gao X, Hu W, Qian D, Bai X, He H, Li L et al (2023) The mechanisms of Ferroptosis under hypoxia. Cell Mol Neurobiol 43:3329\u20133341. https:\/\/doi.org\/10.1007\/s10571-023-01388-8","journal-title":"Cell Mol Neurobiol"},{"key":"3021_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.coph.2022.102194","volume":"63","author":"M Gharagozloo","year":"2022","unstructured":"Gharagozloo M, Bannon R, Calabresi PA (2022) Breaking the barriers to remyelination in multiple sclerosis. Curr Opin Pharmacol 63:102194. https:\/\/doi.org\/10.1016\/j.coph.2022.102194","journal-title":"Curr Opin Pharmacol"},{"key":"3021_CR50","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1093\/brain\/awu331","volume":"138","author":"P Giannetti","year":"2015","unstructured":"Giannetti P, Politis M, Su P, Turkheimer FE, Malik O, Keihaninejad S et al (2015) Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome. Brain 138:110\u2013119. https:\/\/doi.org\/10.1093\/brain\/awu331","journal-title":"Brain"},{"key":"3021_CR51","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00255","volume":"9","author":"KM Gillen","year":"2018","unstructured":"Gillen KM, Mubarak M, Nguyen TD, Pitt D (2018) Significance and in vivo detection of iron-laden microglia in white matter multiple sclerosis lesions. Front Immunol 9:255. https:\/\/doi.org\/10.3389\/fimmu.2018.00255","journal-title":"Front Immunol"},{"key":"3021_CR52","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-026-02984-w","volume":"151","author":"A Giordano","year":"2026","unstructured":"Giordano A, Stridh P, Preziosa P, Pisa M, Lerma-Martin C, Sorosina M et al (2026) A HIF1A variant impacts long-term disability and smoldering inflammation in multiple sclerosis. Acta Neuropathol 151:12. https:\/\/doi.org\/10.1007\/s00401-026-02984-w","journal-title":"Acta Neuropathol"},{"key":"3021_CR53","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1435306","volume":"15","author":"X Gong","year":"2024","unstructured":"Gong X, Yang S-Y, Wang Z-Y, Tang M (2024) The role of hypoxic microenvironment in autoimmune diseases. Front Immunol 15:1435306. https:\/\/doi.org\/10.3389\/fimmu.2024.1435306","journal-title":"Front Immunol"},{"key":"3021_CR54","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/0306-9877(90)90081-o","volume":"33","author":"SF Gottlieb","year":"1990","unstructured":"Gottlieb SF, Smith JE, Neubauer RA (1990) The etiology of multiple sclerosis: a new and extended vascular-ischemic model. Med Hypotheses 33:23\u201329. https:\/\/doi.org\/10.1016\/0306-9877(90)90081-o","journal-title":"Med Hypotheses"},{"key":"3021_CR55","doi-asserted-by":"publisher","first-page":"2465","DOI":"10.1158\/1535-7163.MCT-16-0167","volume":"15","author":"C Gstalder","year":"2016","unstructured":"Gstalder C, Ader I, Cuvillier O (2016) FTY720 (Fingolimod) inhibits HIF1 and HIF2 signaling, promotes vascular remodeling, and chemosensitizes in renal cell carcinoma animal model. Mol Cancer Ther 15:2465\u20132474. https:\/\/doi.org\/10.1158\/1535-7163.MCT-16-0167","journal-title":"Mol Cancer Ther"},{"key":"3021_CR56","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/brain\/awv398","volume":"139","author":"L Haider","year":"2016","unstructured":"Haider L, Zrzavy T, Hametner S, H\u00f6ftberger R, Bagnato F, Grabner G et al (2016) The topograpy of demyelination and neurodegeneration in the multiple sclerosis brain. Brain 139:807\u2013815. https:\/\/doi.org\/10.1093\/brain\/awv398","journal-title":"Brain"},{"key":"3021_CR57","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1093\/brain\/awaa427","volume":"144","author":"SK Halder","year":"2020","unstructured":"Halder SK, Milner R (2020) Hypoxia in multiple sclerosis; is it the chicken or the egg? Brain 144:402\u2013410. https:\/\/doi.org\/10.1093\/brain\/awaa427","journal-title":"Brain"},{"key":"3021_CR58","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1002\/ana.23974","volume":"74","author":"S Hametner","year":"2013","unstructured":"Hametner S, Wimmer I, Haider L, Pfeifenbring S, Br\u00fcck W, Lassmann H (2013) Iron and neurodegeneration in the multiple sclerosis brain. Ann Neurol 74:848\u2013861. https:\/\/doi.org\/10.1002\/ana.23974","journal-title":"Ann Neurol"},{"key":"3021_CR59","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.3174\/ajnr.A4726","volume":"37","author":"DM Harrison","year":"2016","unstructured":"Harrison DM, Li X, Liu H, Jones CK, Caffo B, Calabresi PA et al (2016) Lesion heterogeneity on high-field susceptibility MRI is associated with multiple sclerosis severity. AJNR Am J Neuroradiol 37:1447\u20131453. https:\/\/doi.org\/10.3174\/ajnr.A4726","journal-title":"AJNR Am J Neuroradiol"},{"key":"3021_CR60","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41582-022-00624-x","volume":"18","author":"LM Healy","year":"2022","unstructured":"Healy LM, Stratton JA, Kuhlmann T, Antel J (2022) The role of glial cells in multiple sclerosis disease progression. Nat Rev Neurol 18:237\u2013248. https:\/\/doi.org\/10.1038\/s41582-022-00624-x","journal-title":"Nat Rev Neurol"},{"key":"3021_CR61","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.freeradbiomed.2018.07.018","volume":"133","author":"K Hirota","year":"2019","unstructured":"Hirota K (2019) An intimate crosstalk between iron homeostasis and oxygen metabolism regulated by the hypoxia-inducible factors (HIFs). Free Radic Biol Med 133:118\u2013129. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.07.018","journal-title":"Free Radic Biol Med"},{"key":"3021_CR62","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1177\/1352458518791680","volume":"24","author":"H H\u00f6gel","year":"2018","unstructured":"H\u00f6gel H, Rissanen E, Vuorimaa A, Airas L (2018) Positron emission tomography imaging in evaluation of MS pathology in vivo. Mult Scler 24:1399\u20131412. https:\/\/doi.org\/10.1177\/1352458518791680","journal-title":"Mult Scler"},{"key":"3021_CR63","doi-asserted-by":"publisher","first-page":"2755","DOI":"10.1093\/brain\/awr182","volume":"134","author":"OW Howell","year":"2011","unstructured":"Howell OW, Reeves CA, Nicholas R, Carassiti D, Radotra B, Gentleman SM et al (2011) Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis. Brain 134:2755\u20132771. https:\/\/doi.org\/10.1093\/brain\/awr182","journal-title":"Brain"},{"key":"3021_CR64","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/82_2010_74","volume":"345","author":"HZ Imtiyaz","year":"2010","unstructured":"Imtiyaz HZ, Simon MC (2010) Hypoxia-inducible factors as essential regulators of inflammation. Curr Top Microbiol Immunol 345:105\u2013120. https:\/\/doi.org\/10.1007\/82_2010_74","journal-title":"Curr Top Microbiol Immunol"},{"key":"3021_CR65","doi-asserted-by":"publisher","DOI":"10.1186\/s41232-020-00117-8","volume":"40","author":"T Ishida","year":"2020","unstructured":"Ishida T, Nakao S, Ueyama T, Harada Y, Kawamura T (2020) Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1. Inflamm Regen 40:8. https:\/\/doi.org\/10.1186\/s41232-020-00117-8","journal-title":"Inflamm Regen"},{"key":"3021_CR66","doi-asserted-by":"publisher","first-page":"4697","DOI":"10.4049\/jimmunol.180.7.4697","volume":"180","author":"J Jantsch","year":"2008","unstructured":"Jantsch J, Chakravortty D, Turza N, Prechtel AT, Buchholz B, Gerlach RG et al (2008) Hypoxia and hypoxia-inducible factor-1 alpha modulate lipopolysaccharide-induced dendritic cell activation and function. J Immunol 180:4697\u20134705. https:\/\/doi.org\/10.4049\/jimmunol.180.7.4697","journal-title":"J Immunol"},{"key":"3021_CR67","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1111\/bpa.12813","volume":"30","author":"A Junker","year":"2020","unstructured":"Junker A, Wozniak J, Voigt D, Scheidt U, Antel J, Wegner C et al (2020) Extensive subpial cortical demyelination is specific to multiple sclerosis. Brain Pathol 30:641\u2013652. https:\/\/doi.org\/10.1111\/bpa.12813","journal-title":"Brain Pathol"},{"key":"3021_CR68","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molcel.2008.04.009","volume":"30","author":"WG Kaelin","year":"2008","unstructured":"Kaelin WG, Ratcliffe PJ (2008) Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell 30:393\u2013402. https:\/\/doi.org\/10.1016\/j.molcel.2008.04.009","journal-title":"Mol Cell"},{"key":"3021_CR69","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp-2014-310051","volume":"87","author":"N Kappus","year":"2016","unstructured":"Kappus N, Weinstock-Guttman B, Hagemeier J, Kennedy C, Melia R, Carl E et al (2016) Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 87:181\u2013187. https:\/\/doi.org\/10.1136\/jnnp-2014-310051","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3021_CR70","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/eji.201142053","volume":"42","author":"T K\u00f6hler","year":"2012","unstructured":"K\u00f6hler T, Reizis B, Johnson RS, Weighardt H, F\u00f6rster I (2012) Influence of hypoxia-inducible factor 1\u03b1 on dendritic cell differentiation and migration. Eur J Immunol 42:1226\u20131236. https:\/\/doi.org\/10.1002\/eji.201142053","journal-title":"Eur J Immunol"},{"key":"3021_CR71","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4049\/jimmunol.0800167","volume":"184","author":"H Kojima","year":"2010","unstructured":"Kojima H, Kobayashi A, Sakurai D, Kanno Y, Hase H, Takahashi R et al (2010) Differentiation stage-specific requirement in hypoxia-inducible factor-1alpha-regulated glycolytic pathway during murine B cell development in bone marrow. J Immunol 184:154\u2013163. https:\/\/doi.org\/10.4049\/jimmunol.0800167","journal-title":"J Immunol"},{"key":"3021_CR72","doi-asserted-by":"publisher","DOI":"10.1111\/ene.16529","volume":"32","author":"N Krajnc","year":"2025","unstructured":"Krajnc N, Hofer L, F\u00f6ttinger F, Dal-Bianco A, Leutmezer F, Kornek B et al (2025) Paramagnetic rim lesions are associated with inner retinal layer thinning and progression independent of relapse activity in multiple sclerosis. Eur J Neurol 32:e16529. https:\/\/doi.org\/10.1111\/ene.16529","journal-title":"Eur J Neurol"},{"key":"3021_CR73","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00401-016-1653-y","volume":"133","author":"T Kuhlmann","year":"2017","unstructured":"Kuhlmann T, Ludwin S, Prat A, Antel J, Br\u00fcck W, Lassmann H (2017) An updated histological classification system for multiple sclerosis lesions. Acta Neuropathol 133:13\u201324. https:\/\/doi.org\/10.1007\/s00401-016-1653-y","journal-title":"Acta Neuropathol"},{"key":"3021_CR74","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1093\/brain\/awn096","volume":"131","author":"T Kuhlmann","year":"2008","unstructured":"Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Br\u00fcck W (2008) Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 131:1749\u20131758. https:\/\/doi.org\/10.1093\/brain\/awn096","journal-title":"Brain"},{"key":"3021_CR75","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","volume":"22","author":"T Kuhlmann","year":"2023","unstructured":"Kuhlmann T, Moccia M, Coetzee T, Cohen JA, Correale J, Graves J et al (2023) Time for a new mechanism-driven framework to define multiple sclerosis progression. Lancet Neurol 22:78\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(22)00289-7","journal-title":"Lancet Neurol"},{"key":"3021_CR76","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000001157","author":"L Amezcua","year":"2022","unstructured":"Amezcua L (2022) Progressive multiple sclerosis. Continuum (Minneap Minn). https:\/\/doi.org\/10.1212\/CON.0000000000001157","journal-title":"Continuum (Minneap Minn)"},{"key":"3021_CR77","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0022-510X(02)00421-5","volume":"206","author":"H Lassmann","year":"2003","unstructured":"Lassmann H (2003) Hypoxia-like tissue injury as a component of multiple sclerosis lesions. J Neurol Sci 206:187\u2013191. https:\/\/doi.org\/10.1016\/S0022-510X(02)00421-5","journal-title":"J Neurol Sci"},{"key":"3021_CR78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.03116","volume":"9","author":"H Lassmann","year":"2019","unstructured":"Lassmann H (2019) Pathogenic mechanisms associated with different clinical courses of multiple sclerosis. Front Immunol 9:3116. https:\/\/doi.org\/10.3389\/fimmu.2018.03116","journal-title":"Front Immunol"},{"key":"3021_CR79","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/nrneurol.2012.168","volume":"8","author":"H Lassmann","year":"2012","unstructured":"Lassmann H, van Horssen J, Mahad D (2012) Progressive multiple sclerosis: pathology and pathogenesis. Nat Rev Neurol 8:647\u2013656. https:\/\/doi.org\/10.1038\/nrneurol.2012.168","journal-title":"Nat Rev Neurol"},{"key":"3021_CR80","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0050-14.2015","author":"N Le Moan","year":"2015","unstructured":"Le Moan N, Baeten KM, Rafalski VA, Ryu JK, Rios Coronado PE, Bedard C et al (2015) Hypoxia inducible factor-1\u03b1 in astrocytes and\/or Myeloid cells is not required for the development of autoimmune demyelinating disease. eNeuro. https:\/\/doi.org\/10.1523\/ENEURO.0050-14.2015","journal-title":"eNeuro"},{"key":"3021_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00084","volume":"9","author":"SM Leibowitz","year":"2016","unstructured":"Leibowitz SM, Yan J (2016) NF-\u03baB pathways in the pathogenesis of multiple sclerosis and the therapeutic implications. Front Mol Neurosci 9:84. https:\/\/doi.org\/10.3389\/fnmol.2016.00084","journal-title":"Front Mol Neurosci"},{"key":"3021_CR82","doi-asserted-by":"publisher","first-page":"50","DOI":"10.33594\/000000199","volume":"27","author":"T Leu","year":"2019","unstructured":"Leu T, Sch\u00fctzhold V, Fandrey J, Ferenz KB (2019) When the brain yearns for oxygen. Neurosignals 27:50\u201361. https:\/\/doi.org\/10.33594\/000000199","journal-title":"Neurosignals"},{"key":"3021_CR83","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1007\/s00702-016-1661-z","volume":"124","author":"M Levite","year":"2017","unstructured":"Levite M (2017) Glutamate, T cells and multiple sclerosis. J Neural Transm 124:775\u2013798. https:\/\/doi.org\/10.1007\/s00702-016-1661-z","journal-title":"J Neural Transm"},{"key":"3021_CR84","doi-asserted-by":"crossref","unstructured":"Lin N, Simon MC (2016) Hypoxia-inducible factors: key regulators of myeloid cells during inflammation. https:\/\/www.jci.org\/articles\/view\/84426\/table\/1. Accessed 9 Apr 2025","DOI":"10.1172\/JCI84426"},{"key":"3021_CR85","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jneuroim.2012.02.015","volume":"246","author":"RP Lisak","year":"2012","unstructured":"Lisak RP, Benjamins JA, Nedelkoska L, Barger JL, Ragheb S, Fan B et al (2012) Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. J Neuroimmunol 246:85\u201395. https:\/\/doi.org\/10.1016\/j.jneuroim.2012.02.015","journal-title":"J Neuroimmunol"},{"key":"3021_CR86","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jneuroim.2017.05.004","volume":"309","author":"RP Lisak","year":"2017","unstructured":"Lisak RP, Nedelkoska L, Benjamins JA, Schalk D, Bealmear B, Touil H et al (2017) B cells from patients with multiple sclerosis induce cell death via apoptosis in neurons in vitro. J Neuroimmunol 309:88\u201399. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.05.004","journal-title":"J Neuroimmunol"},{"key":"3021_CR87","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2025.114745","volume":"157","author":"T Liu","year":"2025","unstructured":"Liu T, Huang Y, Wang Y, Shen H (2025) Disrupting the immune homeostasis: the emerging role of macrophage ferroptosis in autoimmune diseases. Int Immunopharmacol 157:114745. https:\/\/doi.org\/10.1016\/j.intimp.2025.114745","journal-title":"Int Immunopharmacol"},{"key":"3021_CR88","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.expneurol.2011.11.040","volume":"233","author":"B L\u00f3pez-Hern\u00e1ndez","year":"2012","unstructured":"L\u00f3pez-Hern\u00e1ndez B, Posadas I, Podlesniy P, Abad MA, Trullas R, Ce\u00f1a V (2012) HIF-1\u03b1 is neuroprotective during the early phases of mild hypoxia in rat cortical neurons. Exp Neurol 233:543\u2013554. https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.040","journal-title":"Exp Neurol"},{"key":"3021_CR89","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","volume":"83","author":"FD Lublin","year":"2014","unstructured":"Lublin FD, Reingold SC, Cohen JA, Cutter GR, S\u00f8rensen PS, Thompson AJ et al (2014) Defining the clinical course of multiple sclerosis: the 2013 revisions. Neurology 83:278\u2013286. https:\/\/doi.org\/10.1212\/WNL.0000000000000560","journal-title":"Neurology"},{"key":"3021_CR90","doi-asserted-by":"publisher","first-page":"104701","DOI":"10.1016\/j.ebiom.2023.104701","volume":"94","author":"P Maggi","year":"2023","unstructured":"Maggi P, Bulcke CV, Pedrini E, Bugli C, Sellimi A, Wynen M et al (2023) B cell depletion therapy does not resolve chronic active multiple sclerosis lesions. EBioMedicine 94:104701\u2013104711. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104701","journal-title":"EBioMedicine"},{"key":"3021_CR91","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/S1474-4422(14)70256-X","volume":"14","author":"DH Mahad","year":"2015","unstructured":"Mahad DH, Trapp BD, Lassmann H (2015) Pathological mechanisms in progressive multiple sclerosis. Lancet Neurol 14:183\u2013193. https:\/\/doi.org\/10.1016\/S1474-4422(14)70256-X","journal-title":"Lancet Neurol"},{"key":"3021_CR92","doi-asserted-by":"publisher","DOI":"10.3390\/cells10092340","volume":"10","author":"MI Malkov","year":"2021","unstructured":"Malkov MI, Lee CT, Taylor CT (2021) Regulation of the hypoxia-inducible factor (HIF) by pro-inflammatory cytokines. Cells 10:2340. https:\/\/doi.org\/10.3390\/cells10092340","journal-title":"Cells"},{"key":"3021_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-08477-6","volume":"12","author":"M Marcille","year":"2022","unstructured":"Marcille M, Hurtado R\u00faa S, Tyshkov C, Jaywant A, Comunale J, Kaunzner UW et al (2022) Disease correlates of rim lesions on quantitative susceptibility mapping in multiple sclerosis. Sci Rep 12:4411. https:\/\/doi.org\/10.1038\/s41598-022-08477-6","journal-title":"Sci Rep"},{"key":"3021_CR94","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1177\/1352458514564485","volume":"21","author":"RA Marrie","year":"2015","unstructured":"Marrie RA, Reider N, Cohen J, Stuve O, Trojano M, Cutter G et al (2015) A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis. Mult Scler 21:318\u2013331. https:\/\/doi.org\/10.1177\/1352458514564485","journal-title":"Mult Scler"},{"key":"3021_CR95","doi-asserted-by":"publisher","first-page":"2503","DOI":"10.1042\/CS20170981","volume":"131","author":"S Martinez Sosa","year":"2017","unstructured":"Martinez Sosa S, Smith KJ (2017) Understanding a role for hypoxia in lesion formation and location in the deep and periventricular white matter in small vessel disease and multiple sclerosis. Clin Sci (Lond) 131:2503\u20132524. https:\/\/doi.org\/10.1042\/CS20170981","journal-title":"Clin Sci (Lond)"},{"key":"3021_CR96","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1080\/14737175.2022.2143265","volume":"22","author":"MS Martire","year":"2022","unstructured":"Martire MS, Moiola L, Rocca MA, Filippi M, Absinta M (2022) What is the potential of paramagnetic rim lesions as diagnostic indicators in multiple sclerosis? Expert Rev Neurother 22:829\u2013837. https:\/\/doi.org\/10.1080\/14737175.2022.2143265","journal-title":"Expert Rev Neurother"},{"key":"3021_CR97","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1002\/glia.24478","volume":"72","author":"V Mattera","year":"2024","unstructured":"Mattera V, Occhiuzzi F, Correale J, Pasquini JM (2024) Remyelinating effect driven by transferrin-loaded extracellular vesicles. Glia 72:338\u2013361. https:\/\/doi.org\/10.1002\/glia.24478","journal-title":"Glia"},{"key":"3021_CR98","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.cmet.2020.08.002","volume":"32","author":"AF McGettrick","year":"2020","unstructured":"McGettrick AF, O\u2019Neill LAJ (2020) The role of HIF in immunity and inflammation. Cell Metab 32:524\u2013536. https:\/\/doi.org\/10.1016\/j.cmet.2020.08.002","journal-title":"Cell Metab"},{"key":"3021_CR99","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1182\/blood-2012-01-405993","volume":"120","author":"AM McInturff","year":"2012","unstructured":"McInturff AM, Cody MJ, Elliott EA, Glenn JW, Rowley JW, Rondina MT et al (2012) Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 \u03b1. Blood 120:3118\u20133125. https:\/\/doi.org\/10.1182\/blood-2012-01-405993","journal-title":"Blood"},{"key":"3021_CR100","doi-asserted-by":"publisher","first-page":"3008","DOI":"10.1182\/blood-2002-02-0454","volume":"100","author":"KI Mecklenburgh","year":"2002","unstructured":"Mecklenburgh KI, Walmsley SR, Cowburn AS, Wiesener M, Reed BJ, Upton PD et al (2002) Involvement of a ferroprotein sensor in hypoxia-mediated inhibition of neutrophil apoptosis. Blood 100:3008\u20133016. https:\/\/doi.org\/10.1182\/blood-2002-02-0454","journal-title":"Blood"},{"key":"3021_CR101","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0057573","volume":"8","author":"V Mehta","year":"2013","unstructured":"Mehta V, Pei W, Yang G, Li S, Swamy E, Boster A et al (2013) Iron is a sensitive biomarker for inflammation in multiple sclerosis lesions. PLoS ONE 8:e57573. https:\/\/doi.org\/10.1371\/journal.pone.0057573","journal-title":"PLoS ONE"},{"key":"3021_CR102","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-02683-x","volume":"9","author":"X Meng","year":"2018","unstructured":"Meng X, Gr\u00f6tsch B, Luo Y, Knaup KX, Wiesener MS, Chen X-X et al (2018) Hypoxia-inducible factor-1\u03b1 is a critical transcription factor for IL-10-producing B cells in autoimmune disease. Nat Commun 9:251. https:\/\/doi.org\/10.1038\/s41467-017-02683-x","journal-title":"Nat Commun"},{"key":"3021_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.703084","volume":"9","author":"EV Mitroshina","year":"2021","unstructured":"Mitroshina EV, Savyuk MO, Ponimaskin E, Vedunova MV (2021) Hypoxia-inducible factor (HIF) in ischemic stroke and neurodegenerative disease. Front Cell Dev Biol 9:703084. https:\/\/doi.org\/10.3389\/fcell.2021.703084","journal-title":"Front Cell Dev Biol"},{"key":"3021_CR104","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25094581","volume":"25","author":"EV Mitroshina","year":"2024","unstructured":"Mitroshina EV, Vedunova MV (2024) The role of oxygen homeostasis and the HIF-1 factor in the development of neurodegeneration. Int J Mol Sci 25:4581. https:\/\/doi.org\/10.3390\/ijms25094581","journal-title":"Int J Mol Sci"},{"key":"3021_CR105","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/jcp.22761","volume":"227","author":"A Naldini","year":"2012","unstructured":"Naldini A, Morena E, Pucci A, Miglietta D, Riboldi E, Sozzani S et al (2012) Hypoxia affects dendritic cell survival: role of the hypoxia-inducible factor-1\u03b1 and lipopolysaccharide. J Cell Physiol 227:587\u2013595. https:\/\/doi.org\/10.1002\/jcp.22761","journal-title":"J Cell Physiol"},{"key":"3021_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2025.06.008","author":"TPM Nguyen","year":"2025","unstructured":"Nguyen TPM, Alves F, Lane DJR, Bush AI, Ayton S (2025) Triggering ferroptosis in neurodegenerative diseases. Trends Neurosci. https:\/\/doi.org\/10.1016\/j.tins.2025.06.008","journal-title":"Trends Neurosci"},{"key":"3021_CR107","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1515\/revneuro.1996.7.3.177","volume":"7","author":"XJ Nie","year":"1996","unstructured":"Nie XJ, Olsson Y (1996) Endothelin peptides in brain diseases. Rev Neurosci 7:177\u2013186. https:\/\/doi.org\/10.1515\/revneuro.1996.7.3.177","journal-title":"Rev Neurosci"},{"key":"3021_CR108","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/nri.2016.70","volume":"16","author":"LAJ O\u2019Neill","year":"2016","unstructured":"O\u2019Neill LAJ, Kishton RJ, Rathmell J (2016) A guide to immunometabolism for immunologists. Nat Rev Immunol 16:553\u2013565. https:\/\/doi.org\/10.1038\/nri.2016.70","journal-title":"Nat Rev Immunol"},{"key":"3021_CR109","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-023-01598-7","volume":"11","author":"W Oost","year":"2023","unstructured":"Oost W, Huitema AJ, Kats K, Giepmans BNG, Kooistra SM, Eggen BJL et al (2023) Pathological ultrastructural alterations of myelinated axons in normal appearing white matter in progressive multiple sclerosis. Acta Neuropathol Commun 11:100. https:\/\/doi.org\/10.1186\/s40478-023-01598-7","journal-title":"Acta Neuropathol Commun"},{"key":"3021_CR110","doi-asserted-by":"publisher","first-page":"e000154","DOI":"10.1136\/bmjonc-2023-000154","volume":"3","author":"BM Ortmann","year":"2024","unstructured":"Ortmann BM (2024) Hypoxia-inducible factor in cancer: from pathway regulation to therapeutic opportunity. BMJ Oncol 3:e000154. https:\/\/doi.org\/10.1136\/bmjonc-2023-000154","journal-title":"BMJ Oncol"},{"key":"3021_CR111","doi-asserted-by":"publisher","first-page":"S274","DOI":"10.1097\/00005344-200036051-00081","volume":"36","author":"LW Ostrow","year":"2000","unstructured":"Ostrow LW, Langan TJ, Sachs F (2000) Stretch-induced endothelin-1 production by astrocytes. J Cardiovasc Pharmacol 36:S274-277. https:\/\/doi.org\/10.1097\/00005344-200036051-00081","journal-title":"J Cardiovasc Pharmacol"},{"key":"3021_CR112","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.immuni.2014.09.008","volume":"41","author":"A Palazon","year":"2014","unstructured":"Palazon A, Goldrath AW, Nizet V, Johnson RS (2014) HIF transcription factors, inflammation, and immunity. Immunity 41:518\u2013528. https:\/\/doi.org\/10.1016\/j.immuni.2014.09.008","journal-title":"Immunity"},{"key":"3021_CR113","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.10.003","volume":"32","author":"A Palazon","year":"2017","unstructured":"Palazon A, Tyrakis PA, Macias D, Veli\u00e7a P, Rundqvist H, Fitzpatrick S et al (2017) An HIF-1\u03b1\/VEGF-A axis in cytotoxic t cells regulates tumor progression. Cancer Cell 32:669-683.e5. https:\/\/doi.org\/10.1016\/j.ccell.2017.10.003","journal-title":"Cancer Cell"},{"key":"3021_CR114","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1111\/ene.14608","volume":"28","author":"M Petruzzo","year":"2021","unstructured":"Petruzzo M, Reia A, Maniscalco GT, Luiso F, Lanzillo R, Russo CV et al (2021) The Framingham cardiovascular risk score and 5\u2010year progression of multiple sclerosis. Eur J Neurol 28:893\u2013900. https:\/\/doi.org\/10.1111\/ene.14608","journal-title":"Eur J Neurol"},{"key":"3021_CR115","doi-asserted-by":"publisher","first-page":"28","DOI":"10.4161\/cc.7.1.5145","volume":"7","author":"C Peyssonnaux","year":"2008","unstructured":"Peyssonnaux C, Nizet V, Johnson RS (2008) Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle 7:28\u201332. https:\/\/doi.org\/10.4161\/cc.7.1.5145","journal-title":"Cell Cycle"},{"key":"3021_CR116","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.1172\/JCI31370","volume":"117","author":"C Peyssonnaux","year":"2007","unstructured":"Peyssonnaux C, Zinkernagel AS, Schuepbach RA, Rankin E, Vaulont S, Haase VH et al (2007) Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 117:1926\u20131932. https:\/\/doi.org\/10.1172\/JCI31370","journal-title":"J Clin Invest"},{"key":"3021_CR117","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.molimm.2015.08.004","volume":"68","author":"AT Phan","year":"2015","unstructured":"Phan AT, Goldrath AW (2015) Hypoxia-inducible factors regulate T cell metabolism and function. Mol Immunol 68:527\u2013535. https:\/\/doi.org\/10.1016\/j.molimm.2015.08.004","journal-title":"Mol Immunol"},{"key":"3021_CR118","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.13263","author":"M Pisa","year":"2024","unstructured":"Pisa M, Watson JL, Spencer JI, Niblett G, Mahjoub Y, Lockhart A et al (2024) A role for vessel-associated extracellular matrix proteins in multiple sclerosis pathology. Brain Pathol. https:\/\/doi.org\/10.1111\/bpa.13263","journal-title":"Brain Pathol"},{"key":"3021_CR119","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/71555","volume":"6","author":"D Pitt","year":"2000","unstructured":"Pitt D, Werner P, Raine CS (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67\u201370. https:\/\/doi.org\/10.1038\/71555","journal-title":"Nat Med"},{"key":"3021_CR120","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001139","volume":"9","author":"P Preziosa","year":"2022","unstructured":"Preziosa P, Pagani E, Meani A, Moiola L, Rodegher M, Filippi M et al (2022) Slowly expanding lesions predict 9-year multiple sclerosis disease progression. Neurol Neuroimmunol Neuroinflamm 9:e1139. https:\/\/doi.org\/10.1212\/NXI.0000000000001139","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3021_CR121","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.molimm.2019.04.005","volume":"111","author":"T Qian","year":"2019","unstructured":"Qian T, Hong J, Wang L, Wang Z, Lu Z, Li Y et al (2019) Regulation of CD11b by HIF-1\u03b1 and the STAT3 signaling pathway contributes to the immunosuppressive function of B cells in inflammatory bowel disease. Mol Immunol 111:162\u2013171. https:\/\/doi.org\/10.1016\/j.molimm.2019.04.005","journal-title":"Mol Immunol"},{"key":"3021_CR122","doi-asserted-by":"publisher","first-page":"10237","DOI":"10.1073\/pnas.172399499","volume":"99","author":"ME Raichle","year":"2002","unstructured":"Raichle ME, Gusnard DA (2002) Appraising the brain\u2019s energy budget. Proc Natl Acad Sci USA 99:10237\u201310239. https:\/\/doi.org\/10.1073\/pnas.172399499","journal-title":"Proc Natl Acad Sci USA"},{"key":"3021_CR123","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1007\/s00415-014-7569-3","volume":"262","author":"E Raz","year":"2015","unstructured":"Raz E, Branson B, Jensen JH, Bester M, Babb JS, Herbert J et al (2015) Relationship between iron accumulation and white matter injury in multiple sclerosis: a case-control study. J Neurol 262:402\u2013409. https:\/\/doi.org\/10.1007\/s00415-014-7569-3","journal-title":"J Neurol"},{"key":"3021_CR124","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.jns.2008.07.032","volume":"275","author":"WT Regenold","year":"2008","unstructured":"Regenold WT, Phatak P, Makley MJ, Stone RD, Kling MA (2008) Cerebrospinal fluid evidence of increased extra-mitochondrial glucose metabolism implicates mitochondrial dysfunction in multiple sclerosis disease progression. J Neurol Sci 275:106\u2013112. https:\/\/doi.org\/10.1016\/j.jns.2008.07.032","journal-title":"J Neurol Sci"},{"key":"3021_CR125","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-025-02020-0","volume":"13","author":"CJ Riedl","year":"2025","unstructured":"Riedl CJ, Bormann D, Steinmaurer A, Novak A, Testa G, Poldlehner E et al (2025) Inflammation alters myeloid cell and oligodendroglial iron-handling in multiple sclerosis. Acta Neuropathol Commun 13:124. https:\/\/doi.org\/10.1186\/s40478-025-02020-0","journal-title":"Acta Neuropathol Commun"},{"key":"3021_CR126","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1038\/nature06905","volume":"453","author":"J Rius","year":"2008","unstructured":"Rius J, Guma M, Schachtrup C, Akassoglou K, Zinkernagel AS, Nizet V et al (2008) NF-kappaB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1alpha. Nature 453:807\u2013811. https:\/\/doi.org\/10.1038\/nature06905","journal-title":"Nature"},{"key":"3021_CR127","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2217\/imt-2018-0153","volume":"11","author":"RR Robinson","year":"2019","unstructured":"Robinson RR, Dietz AK, Maroof AM, Asmis R, Forsthuber TG (2019) The role of glial\u2013neuronal metabolic cooperation in modulating progression of multiple sclerosis and neuropathic pain. Immunotherapy 11:129\u2013147. https:\/\/doi.org\/10.2217\/imt-2018-0153","journal-title":"Immunotherapy"},{"key":"3021_CR128","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1002\/glia.24380","volume":"71","author":"KS Rosiewicz","year":"2023","unstructured":"Rosiewicz KS, Muinjonov B, Kunz S, Radbruch H, Chen J, J\u00fcttner R et al (2023) HIF prolyl hydroxylase 2\/3 deletion disrupts astrocytic integrity and exacerbates neuroinflammation. Glia 71:2024\u20132044. https:\/\/doi.org\/10.1002\/glia.24380","journal-title":"Glia"},{"key":"3021_CR129","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-022-04428-6","volume":"79","author":"S Ruskamo","year":"2022","unstructured":"Ruskamo S, Raasakka A, Pedersen JS, Martel A, \u0160kubn\u00edk K, Darwish T et al (2022) Human myelin proteolipid protein structure and lipid bilayer stacking. Cell Mol Life Sci 79:419. https:\/\/doi.org\/10.1007\/s00018-022-04428-6","journal-title":"Cell Mol Life Sci"},{"key":"3021_CR130","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41593-022-01221-3","volume":"26","author":"SK Ryan","year":"2023","unstructured":"Ryan SK, Zelic M, Han Y, Teeple E, Chen L, Sadeghi M et al (2023) Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration. Nat Neurosci 26:12\u201326. https:\/\/doi.org\/10.1038\/s41593-022-01221-3","journal-title":"Nat Neurosci"},{"key":"3021_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/srep33249","volume":"6","author":"M Sadeghian","year":"2016","unstructured":"Sadeghian M, Mastrolia V, Rezaei Haddad A, Mosley A, Mullali G, Schiza D et al (2016) Mitochondrial dysfunction is an important cause of neurological deficits in an inflammatory model of multiple sclerosis. Sci Rep 6:33249. https:\/\/doi.org\/10.1038\/srep33249","journal-title":"Sci Rep"},{"key":"3021_CR132","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41586-023-06409-6","volume":"620","author":"LM Sanmarco","year":"2023","unstructured":"Sanmarco LM, Rone JM, Polonio CM, Fernandez Lahore G, Giovannoni F, Ferrara K et al (2023) Lactate limits CNS autoimmunity by stabilizing HIF-1\u03b1 in dendritic cells. Nature 620:881\u2013889. https:\/\/doi.org\/10.1038\/s41586-023-06409-6","journal-title":"Nature"},{"key":"3021_CR133","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.cell.2012.01.021","volume":"148","author":"GL Semenza","year":"2012","unstructured":"Semenza GL (2012) Hypoxia-inducible factors in physiology and medicine. Cell 148:399\u2013408. https:\/\/doi.org\/10.1016\/j.cell.2012.01.021","journal-title":"Cell"},{"key":"3021_CR134","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1111\/j.1750-3639.2004.tb00049.x","volume":"14","author":"B Serafini","year":"2004","unstructured":"Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F (2004) Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14:164\u2013174. https:\/\/doi.org\/10.1111\/j.1750-3639.2004.tb00049.x","journal-title":"Brain Pathol"},{"key":"3021_CR135","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/cmi.2017.12","volume":"14","author":"K Shan","year":"2017","unstructured":"Shan K, Pang R, Zhao C, Liu X, Gao W, Zhang J et al (2017) IL-17-triggered downregulation of miR-497 results in high HIF-1\u03b1 expression and consequent IL-1\u03b2 and IL-6 production by astrocytes in EAE mice. Cell Mol Immunol 14:909\u2013923. https:\/\/doi.org\/10.1038\/cmi.2017.12","journal-title":"Cell Mol Immunol"},{"key":"3021_CR136","doi-asserted-by":"publisher","first-page":"1372","DOI":"10.4049\/jimmunol.1402552","volume":"195","author":"H Shehade","year":"2015","unstructured":"Shehade H, Acolty V, Moser M, Oldenhove G (2015) Cutting edge: hypoxia-inducible factor 1 negatively regulates Th1 function. J Immunol 195:1372\u20131376. https:\/\/doi.org\/10.4049\/jimmunol.1402552","journal-title":"J Immunol"},{"key":"3021_CR137","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53593-8","volume":"15","author":"H Shen","year":"2024","unstructured":"Shen H, Ojo OA, Ding H, Mullen LJ, Xing C, Hossain MI et al (2024) HIF1\u03b1-regulated glycolysis promotes activation-induced cell death and IFN-\u03b3 induction in hypoxic T cells. Nat Commun 15:9394. https:\/\/doi.org\/10.1038\/s41467-024-53593-8","journal-title":"Nat Commun"},{"key":"3021_CR138","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi LZ, Wang R, Huang G, Vogel P, Neale G, Green DR et al (2011) HIF1alpha-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J Exp Med 208:1367\u20131376. https:\/\/doi.org\/10.1084\/jem.20110278","journal-title":"J Exp Med"},{"key":"3021_CR139","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05537-0","volume":"82","author":"Y Shi","year":"2025","unstructured":"Shi Y, Gilkes DM (2025) HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospects. Cell Mol Life Sci 82:44. https:\/\/doi.org\/10.1007\/s00018-024-05537-0","journal-title":"Cell Mol Life Sci"},{"key":"3021_CR140","doi-asserted-by":"publisher","first-page":"103748","DOI":"10.1016\/j.nicl.2025.103748","volume":"45","author":"H-G Shin","year":"2025","unstructured":"Shin H-G, Kim W, Lee JH, Lee H, Nam Y, Kim J et al (2025) Association of iron deposition in MS lesion with remyelination capacity using susceptibility source separation MRI. NeuroImage Clinical 45:103748. https:\/\/doi.org\/10.1016\/j.nicl.2025.103748","journal-title":"NeuroImage Clinical"},{"key":"3021_CR141","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-021-01110-5","volume":"21","author":"TJ Simkins","year":"2021","unstructured":"Simkins TJ, Duncan GJ, Bourdette D (2021) Chronic demyelination and axonal degeneration in multiple sclerosis: pathogenesis and therapeutic implications. Curr Neurol Neurosci Rep 21:26. https:\/\/doi.org\/10.1007\/s11910-021-01110-5","journal-title":"Curr Neurol Neurosci Rep"},{"key":"3021_CR142","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1172\/JCI44490","volume":"121","author":"A Sindrilaru","year":"2011","unstructured":"Sindrilaru A, Peters T, Wieschalka S, Baican C, Baican A, Peter H et al (2011) An unrestrained proinflammatory M1 macrophage population induced by iron impairs wound healing in humans and mice. J Clin Invest 121:985\u2013997. https:\/\/doi.org\/10.1172\/JCI44490","journal-title":"J Clin Invest"},{"key":"3021_CR143","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-024-00816-4","volume":"27","author":"A Soroush","year":"2025","unstructured":"Soroush A, Dunn JF (2025) A hypoxia-inflammation cycle and multiple sclerosis: mechanisms and therapeutic implications. Curr Treat Options Neurol 27:6. https:\/\/doi.org\/10.1007\/s11940-024-00816-4","journal-title":"Curr Treat Options Neurol"},{"key":"3021_CR144","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1007\/s00401-025-02868-5","volume":"149","author":"L Stork","year":"2025","unstructured":"Stork L, Stephan S, Kutllovci A, Br\u00fcck W, Metz I (2025) Impaired remyelination in late-onset multiple sclerosis. Acta Neuropathol 149:30. https:\/\/doi.org\/10.1007\/s00401-025-02868-5","journal-title":"Acta Neuropathol"},{"key":"3021_CR145","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1101\/gad.1881410","volume":"24","author":"N Takeda","year":"2010","unstructured":"Takeda N, O\u2019Dea EL, Doedens A, Kim J, Weidemann A, Stockmann C et al (2010) Differential activation and antagonistic function of HIF-\u03b1 isoforms in macrophages are essential for NO homeostasis. Genes Dev 24:491\u2013501. https:\/\/doi.org\/10.1101\/gad.1881410","journal-title":"Genes Dev"},{"key":"3021_CR146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1073971","author":"Y-Y Tang","year":"2023","unstructured":"Tang Y-Y, Wang D-C, Wang Y-Q, Huang A-F, Xu W-D (2023) Emerging role of hypoxia-inducible factor-1\u03b1 in inflammatory autoimmune diseases: a comprehensive review. Front Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1073971","journal-title":"Front Immunol"},{"key":"3021_CR147","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nature11986","volume":"496","author":"GM Tannahill","year":"2013","unstructured":"Tannahill GM, Curtis AM, Adamik J, Palsson-McDermott EM, McGettrick AF, Goel G et al (2013) Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1. Nature 496:238\u2013242. https:\/\/doi.org\/10.1038\/nature11986","journal-title":"Nature"},{"key":"3021_CR148","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nri.2017.103","volume":"17","author":"CT Taylor","year":"2017","unstructured":"Taylor CT, Colgan SP (2017) Regulation of immunity and inflammation by hypoxia in immunological niches. Nat Rev Immunol 17:774\u2013785. https:\/\/doi.org\/10.1038\/nri.2017.103","journal-title":"Nat Rev Immunol"},{"key":"3021_CR149","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41581-022-00587-8","volume":"18","author":"CT Taylor","year":"2022","unstructured":"Taylor CT, Scholz CC (2022) The effect of HIF on metabolism and immunity. Nat Rev Nephrol 18:573\u2013587. https:\/\/doi.org\/10.1038\/s41581-022-00587-8","journal-title":"Nat Rev Nephrol"},{"key":"3021_CR150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0000853","volume":"2","author":"M Thiel","year":"2007","unstructured":"Thiel M, Caldwell CC, Kreth S, Kuboki S, Chen P, Smith P et al (2007) Targeted deletion of HIF-1alpha gene in T cells prevents their inhibition in hypoxic inflamed tissues and improves septic mice survival. PLoS ONE 2:e853. https:\/\/doi.org\/10.1371\/journal.pone.0000853","journal-title":"PLoS ONE"},{"key":"3021_CR151","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/jnc.12244","volume":"126","author":"P Urrutia","year":"2013","unstructured":"Urrutia P, Aguirre P, Esparza A, Tapia V, Mena NP, Arredondo M et al (2013) Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J Neurochem 126:541\u2013549. https:\/\/doi.org\/10.1111\/jnc.12244","journal-title":"J Neurochem"},{"key":"3021_CR152","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1038\/s41418-023-01195-0","volume":"30","author":"E Van San","year":"2023","unstructured":"Van San E, Debruyne AC, Veeckmans G, Tyurina YY, Tyurin VA, Zheng H et al (2023) Ferroptosis contributes to multiple sclerosis and its pharmacological targeting suppresses experimental disease progression. Cell Death Differ 30:2092\u20132103. https:\/\/doi.org\/10.1038\/s41418-023-01195-0","journal-title":"Cell Death Differ"},{"key":"3021_CR153","doi-asserted-by":"publisher","first-page":"1988","DOI":"10.1523\/JNEUROSCI.5323-07.2008","volume":"28","author":"G Vangeison","year":"2008","unstructured":"Vangeison G, Carr D, Federoff HJ, Rempe DA (2008) The good, the bad, and the cell type-specific roles of hypoxia inducible factor-1\u03b1 in neurons and astrocytes. J Neurosci 28:1988\u20131993. https:\/\/doi.org\/10.1523\/JNEUROSCI.5323-07.2008","journal-title":"J Neurosci"},{"key":"3021_CR154","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/jcp.47.2.129","volume":"47","author":"AJ Wakefield","year":"1994","unstructured":"Wakefield AJ, More LJ, Difford J, McLaughlin JE (1994) Immunohistochemical study of vascular injury in acute multiple sclerosis. J Clin Pathol 47:129\u2013133","journal-title":"J Clin Pathol"},{"key":"3021_CR155","doi-asserted-by":"publisher","first-page":"3176","DOI":"10.1182\/blood-2006-04-018796","volume":"108","author":"SR Walmsley","year":"2006","unstructured":"Walmsley SR, Cowburn AS, Clatworthy MR, Morrell NW, Roper EC, Singleton V et al (2006) Neutrophils from patients with heterozygous germline mutations in the von Hippel Lindau protein (pVHL) display delayed apoptosis and enhanced bacterial phagocytosis. Blood 108:3176\u20133178. https:\/\/doi.org\/10.1182\/blood-2006-04-018796","journal-title":"Blood"},{"key":"3021_CR156","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1084\/jem.20040624","volume":"201","author":"SR Walmsley","year":"2005","unstructured":"Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T et al (2005) Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med 201:105\u2013115. https:\/\/doi.org\/10.1084\/jem.20040624","journal-title":"J Exp Med"},{"key":"3021_CR157","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12975-022-01090-9","volume":"14","author":"J Walther","year":"2023","unstructured":"Walther J, Kirsch EM, Hellwig L, Schmerbeck SS, Holloway PM, Buchan AM et al (2023) Reinventing the penumbra\u2014the emerging clockwork of a multi-modal mechanistic paradigm. Transl Stroke Res 14:643\u2013666. https:\/\/doi.org\/10.1007\/s12975-022-01090-9","journal-title":"Transl Stroke Res"},{"key":"3021_CR158","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1073\/pnas.92.12.5510","volume":"92","author":"GL Wang","year":"1995","unstructured":"Wang GL, Jiang BH, Rue EA, Semenza GL (1995) Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension. Proc Natl Acad Sci USA 92:5510\u20135514. https:\/\/doi.org\/10.1073\/pnas.92.12.5510","journal-title":"Proc Natl Acad Sci USA"},{"key":"3021_CR159","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1038\/cdd.2008.12","volume":"15","author":"A Weidemann","year":"2008","unstructured":"Weidemann A, Johnson RS (2008) Biology of HIF-1\u03b1. Cell Death Differ 15:621\u2013627. https:\/\/doi.org\/10.1038\/cdd.2008.12","journal-title":"Cell Death Differ"},{"key":"3021_CR160","doi-asserted-by":"publisher","first-page":"2756","DOI":"10.1093\/brain\/awz201","volume":"142","author":"M Wentling","year":"2019","unstructured":"Wentling M, Lopez-Gomez C, Park H-J, Amatruda M, Ntranos A, Aramini J et al (2019) A metabolic perspective on CSF-mediated neurodegeneration in multiple sclerosis. Brain 142:2756\u20132774. https:\/\/doi.org\/10.1093\/brain\/awz201","journal-title":"Brain"},{"key":"3021_CR161","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/path.2582","volume":"219","author":"ME Witte","year":"2009","unstructured":"Witte ME, B\u00f8 L, Rodenburg RJ, Belien JA, Musters R, Hazes T et al (2009) Enhanced number and activity of mitochondria in multiple sclerosis lesions. J Pathol 219:193\u2013204. https:\/\/doi.org\/10.1002\/path.2582","journal-title":"J Pathol"},{"key":"3021_CR162","doi-asserted-by":"publisher","DOI":"10.1038\/s41583-024-00823-z","author":"MS Woo","year":"2024","unstructured":"Woo MS, Engler JB, Friese MA (2024) The neuropathobiology of multiple sclerosis. Nat Rev Neurosci. https:\/\/doi.org\/10.1038\/s41583-024-00823-z","journal-title":"Nat Rev Neurosci"},{"key":"3021_CR163","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1016\/j.cell.2024.05.031","volume":"187","author":"MS Woo","year":"2024","unstructured":"Woo MS, Mayer C, Binkle-Ladisch L, Sonner JK, Rosenkranz SC, Shaposhnykov A et al (2024) STING orchestrates the neuronal inflammatory stress response in multiple sclerosis. Cell 187:4043-4060.e30. https:\/\/doi.org\/10.1016\/j.cell.2024.05.031","journal-title":"Cell"},{"key":"3021_CR164","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.861885","volume":"13","author":"F Yang","year":"2022","unstructured":"Yang F, Hu T, He K, Ying J, Cui H (2022) Multiple sclerosis and the risk of cardiovascular diseases: a Mendelian randomization study. Front Immunol 13:861885. https:\/\/doi.org\/10.3389\/fimmu.2022.861885","journal-title":"Front Immunol"},{"key":"3021_CR165","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1083\/jcb.201803152","volume":"217","author":"G Yellen","year":"2018","unstructured":"Yellen G (2018) Fueling thought: management of glycolysis and oxidative phosphorylation in neuronal metabolism. J Cell Biol 217:2235\u20132246. https:\/\/doi.org\/10.1083\/jcb.201803152","journal-title":"J Cell Biol"},{"key":"3021_CR166","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200477","volume":"12","author":"HYF Yong","year":"2025","unstructured":"Yong HYF, Jain RW, Goiko M, Batty NJ, Phillips S, Ghuman M et al (2025) Angiogenesis and hypoxia biomarkers are dysregulated in progressive multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 12:e200477. https:\/\/doi.org\/10.1212\/NXI.0000000000200477","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"3021_CR167","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41582-021-00581-x","volume":"18","author":"HYF Yong","year":"2022","unstructured":"Yong HYF, Yong VW (2022) Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis. Nat Rev Neurol 18:40\u201355. https:\/\/doi.org\/10.1038\/s41582-021-00581-x","journal-title":"Nat Rev Neurol"},{"key":"3021_CR168","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.bbrc.2014.02.062","volume":"448","author":"G Zhao","year":"2014","unstructured":"Zhao G, Liu Y, Fang J, Chen Y, Li H, Gao K (2014) Dimethyl fumarate inhibits the expression and function of hypoxia-inducible factor-1\u03b1 (HIF-1\u03b1). Biochem Biophys Res Commun 448:303\u2013307. https:\/\/doi.org\/10.1016\/j.bbrc.2014.02.062","journal-title":"Biochem Biophys Res Commun"},{"key":"3021_CR169","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1038\/s42255-025-01379-7","volume":"7","author":"Q Zhao","year":"2025","unstructured":"Zhao Q, Li J, Feng J, Wang X, Liu Y, Wang F et al (2025) Cholesterol metabolic reprogramming mediates microglia-induced chronic neuroinflammation and hinders neurorestoration following stroke. Nat Metab 7:2099\u20132116. https:\/\/doi.org\/10.1038\/s42255-025-01379-7","journal-title":"Nat Metab"},{"key":"3021_CR170","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001138","volume":"9","author":"N Zinger","year":"2022","unstructured":"Zinger N, Ponath G, Sweeney E, Nguyen TD, Lo CH, Diaz I et al (2022) Dimethyl fumarate reduces inflammation in chronic active multiple sclerosis lesions. Neurol Neuroimmunol Neuroinflamm 9:e1138. https:\/\/doi.org\/10.1212\/NXI.0000000000001138","journal-title":"Neurol Neuroimmunol Neuroinflamm"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-026-03021-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-026-03021-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:50:20Z","timestamp":1777373420000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-026-03021-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,28]]},"references-count":170,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["3021"],"URL":"https:\/\/doi.org\/10.1007\/s00401-026-03021-6","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,28]]},"assertion":[{"value":"23 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"49"}}